Dianthus Therapeutics (DNTH) Misses Q1 EPS by 82c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.82). Revenue for the quarter came in at $1.16 million.
For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
- Active options: NVDA TSLA AAPL MU INTC AMZN SPCX MSTR GOOGL AMD
- Citi maintains neutral stance on European equities despite rally
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
